Prescribing information

IMPORTANT: Please be advised hereafter you find the SmPC for Metalyse® as approved by EMA for the countries of the European Union.

In other areas the wording of the respective prescribing information may differ. If you are from outside the EU, please always refer to the current prescribing information as approved in your country.


Vials containing tenecteplase (a recombinant fibrin-specific plasminogen activator) dry powder 6,000 units (30mg), 8,000 units (40mg) or 10,000 units (50mg).

Summary of product characteristics - Metalyse 6,000 units (30 mg)


Packshot Metalyse®